Resource Utilization and Costs of Schizophrenia Patients Treated with Olanzapine versus Quetiapine in a Medicaid Population-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Resource Utilization and Costs of Schizophrenia Patients Treated with Olanzapine versus Quetiapine in a Medicaid Population

Published:2009-07 Issue:5 Volume:12 Page:708-715
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Yu Andrew P.,Atanasov Pavel,Ben-Hamadi Rym,Birnbaum Howard,Stensland Michael D.,Philips Glenn

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference35 articles.

1. The economic burden of schizophrenia in the United States in 2002;Wu;J Clin Psychiatry,2005

2. Practice Guideline for the Treatment of Patients with Schizophrenia;American Psychiatric Association,2004

3. Antipsychotic use and expenditure in the United States;Aparasu;Psychiatr Serv,2006

4. Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic;Stroup;Am J Psychiatry,2006

5. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia;Lieberman;N Engl J Med,2005

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic Review of Real-World Treatment Patterns of Oral Antipsychotics and Associated Economic Burden in Patients with Schizophrenia in the United States;Advances in Therapy;2022-07-18

2. Health Care Resource Utilization and Costs for Patients with Tardive Dyskinesia;Journal of Managed Care & Specialty Pharmacy;2019-07

3. Cost-effectiveness of 3-month paliperidone therapy for chronic schizophrenia in the Netherlands;Journal of Medical Economics;2017-08-14

4. Health Care Utilization and Treatment Persistence Associated with Oral Paliperidone and Lurasidone in Schizophrenia Treatment;Journal of Managed Care & Specialty Pharmacy;2015-09

5. Systematic Literature Review of the Methods Used to Compare Newer Second-Generation Agents for the Management of Schizophrenia: A focus on Health Technology Assessment;PharmacoEconomics;2015-05-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3